Pfizer has raised its full-year profit guidance as its cost-cutting efforts build steam and US President Donald Trump pushes drugmakers to slash their prices.
隨著成本削減措施逐步見效，以及美國總統唐納德?特朗普(Donald Trump)敦促制藥商降低藥價，輝瑞(Pfizer)上調了全年利潤指引。
您已閱讀9%（228字），剩余91%（2176字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。